Health Advances Blog

Reflections on Healthcare & Life Sciences Innovation

Skip to content
Menu
  • Home
  • About
  • COVID-19 Impact
  • Visit Our Website
  • Contact Us

Tag: oncology

The Humira Biosimilars have Arrived! Will They Make a Difference?
  • by healthadvances
  • Posted on February 22, 2023

The Humira Biosimilars Have Arrived! Will They Make a Difference?

Read More
Maturation of Modalities and Targeting Strategies in Oncology
  • by healthadvances
  • Posted on January 4, 2023

Maturation of Modalities and Targeting Strategies in Oncology: A Review of Recent and Upcoming Approvals

Read More
Digital Biomarkers
  • by healthadvances
  • Posted on July 21, 2022

Digital Biomarkers – The Future of Precision Medicine

Read More
mRNA Technology - Messenger RNA Technologies - Next Generation
  • by healthadvances
  • Posted on June 24, 2022June 24, 2022

From Treating Cancer to Curing Cancer – The Promise of mRNA Vaccines in Oncology

Read More
ASCO 2022
  • by healthadvances
  • Posted on June 16, 2022June 16, 2022

ASCO 2022: Striving to Ensure No Patient is Left Behind

Read More
  • by healthadvances
  • Posted on July 30, 2020January 13, 2021

Value Creation in Molecular Diagnostics: A Game of Luck or Skill?

Read More
  • by healthadvances
  • Posted on March 30, 2020April 13, 2020

Key Trends and Developments in the Chinese Oncology Market

Read More
  • by healthadvances
  • Posted on October 14, 2019April 13, 2020

Key Takeaways from ESMO 2019

Read More
  • by healthadvances
  • Posted on June 7, 2019April 13, 2020

Highlights from Health Advances Executive Panel – Precision Medicine: Oncology and Beyond

Read More
  • by healthadvances
  • Posted on April 16, 2019April 13, 2020

Better Market Access in China – Government Improves Pricing and Reimbursement Environment

Read More
  • by healthadvances
  • Posted on April 7, 2019April 13, 2020

Keytruda, a case study for the improved regulatory environment in China

Read More
  • by healthadvances
  • Posted on April 4, 2019April 13, 2020

Liquid Biopsy: Tailwinds at Last

Read More
  • by healthadvances
  • Posted on December 19, 2018April 13, 2020

The Year That Was: Oncology Edition

Read More
  • by healthadvances
  • Posted on March 14, 2018April 15, 2020

Seattle’s Journey to the Summit of Cancer Commercialization

Read More
  • by healthadvances
  • Posted on July 14, 2015April 15, 2020

CAR-T: The Emperor’s New Clothes or The Second Coming?

Read More
  • by healthadvances
  • Posted on July 2, 2015April 15, 2020

Juno Therapeutics and Celgene Ink 10 Year Deal

Read More

Stay Connected

Enter your email address to subscribe to Health Advances blog and receive notifications of new posts by email.

We use WordPress as our blog publishing platform. By entering your email address, you acknowledge that the information you provide will be transferred to WordPress for processing in accordance with their Privacy Policy and Terms.

Topics of Interest

  • Asia/APAC Markets
  • BioPharma
  • COVID-19
  • Diagnostics and Life Science Tools
  • European Markets
  • Health IT and Digital Health
  • Investors
  • Launch Excellence
  • Market Access & Health Policy
  • MedTech
  • Other

Search Our Blog

Follow Us on Social Media

  • View healthadvances’s profile on Facebook
  • View @healthadvances’s profile on Twitter
  • LinkedIn

Recent Tweets

My Tweets
This website uses cookies. You may choose to continue browsing with cookies or leave the site.

Health Advances Privacy Policy
Create a website or blog at WordPress.com
 

Loading Comments...